What Is Eylea, and Why Does It Matter? Eylea HD (aflibercept) is an injectable prescription medicine used for treating certain eye conditions that can cause vision loss over time. The FDA has now ...

Eylea and the newer Eylea HD are both injectable medications used to treat certain serious eye conditions caused by abnormal blood vessel growth or leakage. The main difference between the two ...

Eylea and Eylea HD are prescription medications used to treat various eye conditions. The dosage and frequency of injections of these drugs vary based on the specific condition and the form of the ...

Regeneron Pharmaceuticals, Inc. (REGN) announced that the FDA has extended the target action dates for Eylea HD (aflibercept) injection 8 mg regulatory submissions. Eylea HD is the higher dose of ...

Results showed both aflibercept 8mg dosing arms were noninferior and clinically equivalent to Eylea based on the change in BCVA score at week 36. The Food and Drug Administration (FDA) has approved ...

Patients with wAMD or DME may transition to Eylea HD every 20 weeks following stable outcomes after 1 year of treatment. The Food and Drug Administration (FDA) has approved extended dosing intervals ...

QUASAR is a global, double-masked, active-controlled Phase 3 trial evaluating the efficacy and safety of EYLEA HD, compared to EYLEA, in patients with RVO. EYLEA HD patients were treated with an ...